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DNA Methylation and Differentiation
by Lesley A. Michalowsky* and Peter A. Jones*
The methylation of specific cytosine residues in DNA has been implicated in regulating gene expression
and facilitatingfunctional specialization ofcellular phenotypes. Generally, the demethylation ofcertain CpG
sites correlates with transcriptional activation ofgenes. 5-Azacytidine is an inhibitor ofDNA methylation
and has been widely used as a potent activator ofsuppressed genetic information. Treatment ofcells with
5-azacytidine results inprofoundphenotypic alterations. The drug-induced hypomethylation ofDNAappar-
ently perturbs DNA-protein interactions that may consequently altertranscriptional activityand cell deter-
mination. The inhibitoryeffectofcytosine methylation maybe exertedviaalteredDNA-protein interactions
specifically or may be transduced by a change in the conformation ofchromatin.
Recent studies have demonstrated that cytosine methylation also plays a central role in parental imprint-
ing, which inturn determines the differential expression ofmaternal andpaternal genomes duringembryo-
genesis. In other words, methylation is the mechanism whereby the embryo retains memory ofthe gametic
originofeachcomponentofgenetic information. Amemoryofthistype wouldprobablypersistduringDNA
replication and cell division as methylation patterns are stable and heritable.
Introduction
The major impetus of molecular biology research is
striving to elucidate the mechanisms governing gene ex-
pression during development. The differentiation ofcells
during embryogenesis involves a complex program of
changes in gene activity that dictates the progression of
cells into functionally specialized phenotypes. Since all
cells in an organism containthe samegenetic information,
developmental switches turn onphenotypic-specific genes
and suppress those genes characteristic of other cell
types. Such developmentally regulated changes in gene
expression are classified as epigenetic (1,2).
DNA methylation is an epigenetic regulator that con-
stitutes one level ofthe information coding system con-
trollingeukaryotic gene expression. The hypomethylation
ofspecific sites in some, but not all, genes correlates with
transcriptional activity (3-5). Furthermore, the in vitro
methylation of genes prior to their introduction into eu-
karyotic cells results in gene silencing(6,7). Methylation
may therefore function to lock certain genes in a tran-
scriptionally inactive state.
Defining the precise role of DNA methylation in eu-
karyotic cells has been difficult (4). For instance, the ex-
pression of some genes is not controlledby DNAmethyl-
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ation, and even in those genes that are regulated by the
modification, methylation at somebut not all sites corre-
lates with gene control. Additionally, some animals con-
tain extremely lowlevels ofDNA5-methylcytosine [e.g.,
Drosophila (8)], whereas the genome ofother animals is
highly methylated (3). There has therefore been a prob-
lem in developing anunequivocal, all-encompassingmodel
to describethe role ofDNAmethylation ingene control.
However, great excitement hasbeengeneratedrecently
byseveralilluminatingstudies. GenomicCpGdinucleotide
clusters were discovered (9), and the absence ofmethyl-
ationatthese siteswasthoughttofunctionallydistinguish
these regions from the remainder of the genome (10).
Chandler and colleagues demonstrated the existence of
allele-specific methylation patternsthat substantiated the
concept that differential methylation may be the dis-
criminatory signal conferring distinctions on otherwise
identicalgenomic sequences(11). Moreover, DNA meth-
ylationwasthenimplicated as amolecularmechanismfor
parental imprinting (12-14). In this chapter, we will dis-
cuss thesefascinatingfindings aswell as the growing evi-
dence that DNAmethylation is one mechanismbywhich
eukaryotes control gene expression during cellular
differentiation.
DNA Methylation Patterns
5-Methylcytosine istheonlymodifiedbaseinvertebrate
DNA. About 3% of cytosines, predominantly in theMICHALOWSKYAND JONES
dinucleotide 5'CpG3, are postreplicatively modified to
5-methylcytosine (15). Significantly, this doublet is under-
represented in eukaryotic DNA (16). The proposed rea-
son for the underrepresentation is that the presence of
the 5-methyl moietyincreases the spontaneous rate ofox-
idative deamination ofthepyrimidine ringresultinginthe
formation ofa thymine base which cannotbe recognized
by repair enzymes, thus resulting in mutational hotspots
(17). Consistent with this explanation is the fact that the
diminishedfrequencyofCpG sequences isusually accom-
panied by an overabundance of TpG and CpA dinucleo-
tides (18). Furthermore, restriction endonuclease sites
containing CpG have a high frequency ofpolymorphism
(19). Thkentogether, the results suggest thatthe remain-
ing CpG dinucleotides in vertebrate genomes have func-
tional importance (20), or have never been methylated.
The distribution ofmethylated cytosine residues in eu-
karyotic DNA is nonrandom. 5-Methylcytosine occurs in
repetitive sequences several-fold more frequently than in
middle repetitive or unique sequences (21,22). Moreover,
the extent and pattern ofgenomic DNA methylation is
species and tissue-specific (22-24). During development,
the generation oftissue-specific patterns may be deter-
minedby denovo sequential changes inmethylationpat-
terns (25-28). The fact that tissue-specific methylation
patterns do exist indicates that such a pattern can be
faithfully inherited in somatic cells. Experiments that
have demonstrated thisphenomenonprovide strong evi-
dence that cytosine DNA modification is associatedwith
the epigenetic control ofgene transcription (29-31).
The dinucleotide CpG is also nonrandomly distributed
in the vertebrate genome (9). Manygenes contain CpGis-
lands, which are GandC-richregions ofDNAwhich have
ahigherfrequency ofCpG dinucleotides thanbulk DNA
(10). CpG islands occurat the 5'end ofhousekeeping and
tissue-specific genes, as well as at the 3' end of some
tissue-specificgenes(32,33). Birdhasestimatedthatthere
may be as many as 30,000 CpG islands in the haploid
mouse genome (9). It is also predicted that CpG islands
will be found associated with the vast majority ofgenes,
especially those that are widely expressed (32). Interest-
ingly, all ofthe CpGislandsthathavebeen examined are
not methylated, with the exception ofthose on the inac-
tive X-chromosome in somatic cells. The CpGdinucleotide
is therefore abundant and notmethylated inthese islands,
whereas it is relatively scarce and predominantly meth-
ylated inthe rest ofthegenome. Itisbelievedthatinthe
germline these clusters are protected from methylation
sothattherespectivegenes arepoisedforearlytranscrip-
tion.
Since 5-methylcytosine occurspredominantly inthe se-
quence CpG (20), methylation sites in double-stranded
DNA are symmetrical. Apotential methylation site could
exist therefore inthree states: unmethylated, hemimeth-
ylated, or symmetrically methylated in both strands.
Fully methylated sites would be converted to hemimeth-
ylated sites as a result ofsemi-conservative DNA repli-
cation (15).
DNA methyltransferase enzymes are responsible for
the maintenance ofmethylation patterns (34). These en-
zymes catalyze the transfer ofthe methyl group from S-
adenosylmethionine (SAM) to the 5-position of speciflc
cytosine residues in DNA. Methyltransferase enzymes
recognize hemimethylated DNA(34) and maintain meth-
ylation patterns with high fidelity (35). Following repli-
cation, the maintenance methylases use the themethyla-
tionpattern on the template strand to restore symmetry
and direct the precise methylation ofthe newly synthe-
sized DNA strand (15). In addition, methyltransferase en-
zymes probably mediate de novo methylation by impos-
ing sequence-specific DNA methylation at sites
previously not methylated (36,37). De novo methylation
has been demonstrated in T-lymphoid cells (38), mouse
embryo fibroblast variants (39), viral systems(40,41), and
during the establishment of immortal murine cell lines
(42). Such alterations in methylation patterns may repre-
sentregulatory signalswhich, directly orindirectly, elicit
changes in gene expression.
Eukaryotic DNA methyltransferase has beenpartially
purified and characterized by several investigators
(34,43-46). However, controversy still exists as to the ex-
istence of two distinct enzymes, since the de novo and
maintenance methyltransferase activities do co-purify
(26,44,46). Initially, the sequence specificities ofthe two
enzymes werethoughttobe different(35,47), butrecently
Bolden etal. suggestedthatbothmethyltransferase reac-
tions are catalyzed by the same enzyme, as the mainte-
nance and de novo methyltransferases share the same
substrate specificities (48). It has also been postulated
that DNAmethyltransferase associatedwiththenuclear
matrixispredominantlyresponsible forthemaintenance
ofinheritable methylationpatterns(49,50), but does also
possess some de novo methylation activity (49).
The methyltransferase activity is inducible by mito-
genic stimuli in a cell cycle-dependent manner that en-
sures conservation ofmethylation patterns(51). Moreover,
Bestorand IngramreportedthatFrienderythroleukemia
cells contained three distinct methyltransferase enzymes
whose relative amounts depended on the proliferative
state ofthe cells (52). Using methyltransferase purified
from these cells, Bestor also demonstrated that the se-
quence specificity ofthe enzyme was conditional on the
amount ofsupercoiling orthephysical conformation ofthe
DNA substrate (53).
DNA Methylation and Protein-DNA
Interactions
5-Methylcytosine affects protein-DNA interactions in
prokaryotes (25) so that methylation ofspecific cytosine
residues ineukaryotes may also alterthe binding ofreg-
ulatory ortranscriptional factors. However, recent experi-
ments in our laboratory have shown no direct effect of
cytosine methylation on the binding ofthe transcription
factorSpl toitsrecognition sequence(54). Similarresults
have been obtained by Doerfler's laboratory for the
adenovirus gene (55), so that the methylation signal in
these genes is presumably transduced by more indirect
mechanisms such as altered chromatin configuration. Al-
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ternatively, the effect ofcytosine methylation onprotein-
DNAinteractions maybe site- andprotein-specific since
the modification does prevent protein bindingto some but
not all upstream sequences of the rat tyrosine
aminotransferase gene (56).
DNAassociatedwithnucleosomes is significantlymore
methylated than DNAin spacerregionsbetweennucleo-
some cores (21,57,58). Moreover, at least 80% of
5-methylcytosine in chromatin is nonrandomly packaged
into nucleosomes that contain histone Hi (59). DNA
methylation may therefore inhibit gene expression via
conformational changes in chromatin. Consistent with
this theory are microinjection experiments that revealed
that chromatin formation mediated the inhibitory effect
of DNA methylation on transcription of the thymidine
kinase gene(60). The expression ofthe thymidine kinase
gene was notblocked by DNAmethylationperse, butby
the formation ofchromatin consisting ofthe methylated
gene reconstituted with histones. Indeed, 5-methyl-
cytosine isinvolvedinthe maintenance ofX-chromosome
inactivation in somatic cells, and this function may be
achieved through condensation ofchromosome structure.
Itremains unclearwhether DNAmethylation is a cause
oraneffectofchromosome compaction. Inactivationofthe
X-chromosome precedes methylationofthemouse HPRT
gene(61)and may therefore stabilize the inactive config-
uration rather than induce it directly. In contrast, Keshet
etal. transfected methylated andunmethylatedM13 con-
structs into mouse L cells and found that the sequences
integrated into the genome, but only the methylated se-
quences assumedthe chromatinconformation characteris-
tic of inactive genes (62). Irrespective of the temporal
events, methylationprobably doesplayarole in the selec-
tive protein-DNA interactions that maintain chromatin
conformation. Sincemethylation patterns arefaithfully in-
herited, the chromatin structure associated with genetic
repression can be stably propagated.
Methylation Inhibitors 5-Azacytidine
and 5-Azadeoxycytidine
Studies using the methylation inhibitors 5-azacytidine
(5-aza-CR) and 5-aza-2'-deoxycytidine (5-aza-CdR) have
provided additional evidence for the role ofmethylation
in gene repression (63). These nucleoside analogs were
originally developed as cancer chemotherapeutic agents
(64)but have nowreceived wide attention as chemical ac-
tivators ofsuppressedgenetic information (65). 5-Aza-CR
selectively activates eukaryotic gene expression and in-
duces dramatic alterations in the differentiated state of
certain eukaryotic cells.
5-Aza-CR and 5-aza-CdR are cytidine analogs with a
nitrogen instead of a carbon atom at position 5 of the
pyrimidinering. Both drugs arephosphorylated intracel-
lularly (64,66), and 5-aza-CR is incorporated into RNA
and DNA, whereas 5-aza-CdR isonlyfoundin DNA(67).
Once incorporated into DNA, the azanucleoside ring can-
not be methylated and the analogs are thought to medi-
ate their remarkable biological effects via inhibition of
DNA methylation (68).
Mechanism of Inhibition of DNA
Methylation by 5-Azacytidine
5-Aza-CR and 5-aza-CdR were shown to inhibit the
methylation ofthe newly synthesized strand of DNA in
C3H1OT1/2 C18 cells (68) and in L1210 cells (69). Inhibi-
tion of the cytosine modification occurred only after in-
corporation ofthe fraudulent baseinto DNA, andthe ex-
tent of inhibition was dependent on the drug
concentration (68,70). However, very extensive demeth-
ylation occurredasthe substitutionofonly5% ofcytosine
residuesby5-azacytosine resultedingreaterthan80% de-
crease in methylation (71). In other words, the presence
of5-azacytosine at a modification site strongly inhibited
the methylation of cytosine residues at unsubstituted
sites.
DrahovskyandMornis(72)and Panakaetal. (70)showed
that the DNA methyltransferase was a processive en-
zyme that remained associated with DNA scanning for
available hemimethylated sites. Thus, the presence of
5-azacytosine in duplex, hemimethylated DNA was pro-
posed to interfere with the progress and functioning of
the enzyme along DNA (71). The incorporation of low
amounts of5-azacytosine into DNAcouldtherefore inac-
tivate the methyltransferases and result in drastic inhi-
bition ofmethylation sites downstreamfromthetrapped
enzyme. This would lead to the considerable decrease in
DNA methylation observed in daughter cells.
Studies that demonstrated adrastic decrease in extract-
able DNA methyltransferase activity after treatment
with 5-aza-CdR implied that the enzyme formed a tight
complex with 5-azacytosine and could not subsequently
be extracted (70,71,73). Treatment ofcells with 5-aza-CR
resulted in the rapidtime- and dose-dependentformation
of tight-binding complex that could not be dissociated
with0.3 M NaCl(71,73). Infact, themethyltransferase in-
hibition was irreversible and required new protein syn-
thesis for recovery of active enzyme and restoration of
5-methylcytosine levels (71).
Santi et al. have proposed a mechanism to explain the
irreversible inhibition ofthe DNAmethyltransferase en-
zyme (74). This model, based on similarities to the
thymidylate synthetase enzyme, proposes anucleophilic
attack by an S-H group at the active site ofthe enzyme
onto the 6 position ofthe pyrimidine ring. Normally the
covalent bond is broken following addition ofthe methyl
group to the 5 position. Since the addition ofthe methyl
groupisblocked, theenzyme-DNAintermediate is stabi-
lized. Consistent with this mechanism is the fact that
methyltransferase inhibition can be mimicked by other
5-substituted analogs such as pseudoisocytidine and
5-fluoro-2'-deoxycytidine (71).
The incorporation of 5-azacytosine into DNA also in-
creases the formation ofstable, protein-DNAcomplexes
with other nuclear proteins (75,76). These tight-binding
complexesbetween specificnonhistoneproteins and DNA
occur at hemimethylated sites created by the incorpora-
tion of5-azacytosine into DNAduring onereplication cy-
cle(76). Suchinteractions mayinvolveregulatoryprotein
factors as well as enzymes associated with DNA. In this
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way, the perturbations of DNA-protein interactions
caused by 5-azacytosine may intervene with normal cel-
lularfunctioningandthusbe repsonsible for some ofthe
profoundchanges ingene expressionelicitedbythe drug.
Altered Phenotypes Induced by
5-Azanucleosides
The pathway ofdifferentiation initiallyinvolves a stage
of determination when precursor cells become deter-
mined to a specific cell lineage. Subsequently, appropri-
ate stimuli induce these lineage-determined cells to en-
ter the commitment phase ofdevelopment and form the
end-stagephenotype. Cellsprimedto differentiate asare-
sult of5-aza-CR treatmentprovide anexcellentsystemfor
analysis ofthe molecular events controllingthe specializa-
tion of cellular phenotypes. 5-Aza-CR treatment is
thought to trigger the determination of cells, and the
presence ofthe drugisnotessentialforpromotion ofthe
commitment phase. Rather, commitment may be under
hormonal (77) or extracellular matrix influences (78).
The dramatic effects ofthese hypomethylating agents
on cell determination have beenwidely demonstrated in
mouse embryo fibroblast cell lines(79). 5-Aza-CR induces
the formation of contractile, striated muscle cells in
C3H1OT½2Cl 8mousefibroblasts 10 to 14days after asin-
gle dose of the analog (80,81). Muscle cells were never
seen inuntreated 10T½/ cultures. The alteredphenotype
was heritable since the myocytes were stable and could
be propagated in the absence offurther drug treatment
(82). In addition, functionally differentiated adipocytes
and chondrocytes alsoemergedafter5-aza-CRtreatment
of 10T½/ cells, so that alterations in differentiation were
not restricted to the muscle phenotype (83). Phenotypic
changeswerenot evenconfinedtothe developmentalline-
age ofthetreatedprecursor cell since epithelial cellswere
induced from 5-aza-CR-treated teratocarcinoma-derived
mesenchymal cells (84). The differentiation ofnonmesen-
chymal cells is also dramatically altered by exposure to
5-aza-CR, asexemplifiedbyvariousleukemiacell differen-
tiation models (73,85,86). Therefore, the effects ofthese
analogs on differentiation are quitegeneral as they have
been confirmedwith diverse lineages invarious celllines
from several different species.
It seems likely that the profound effects of 5-aza-
nucleosides on differentiation may be due to the activa-
tion ofone orafew determination loci whose subsequent
expression defines thephenotype(82). Inthemuscle sys-
tem this determination gene is probably replicated early
in Sphase since itcanbe activatedby5-aza-CR ina5min
exposure ofSphase-synchronized 10T½/ cells(87). Excit-
ingexperiments perfonnedby Lassar et al. have substan-
tiated this theory (88). DNAfrom 5-aza-CR-derived my-
oblasts was transfected into normal 10T½2 cells and
resultedinthe emergenceofmyoblasts at afrequency ex-
pected for the transfer ofonly a few demethylated loci.
Characterization ofthisputative determinationgenewill
beparticularlyinteresting andinformative forelucidation
ofthemechanisms ofcell determination and commitment.
Selective Gene Activation by
5-Azacytidine and
5-Azadeoxycytidine
Thephenotypic changesinvokedbythemethylation in-
hibitors presumably require the concerted activation of
many speciflc genes. One intriguingfeature ofboth ana-
logs is thatthey selectively activategenesinstead ofcaus-
ing genome-wide random derepression.
X-Chromosome Reactivation
DNAmethylation is thought to be involvedin the inac-
tivation ofone ofthetwo X chromosomesin somatic cells
ofmammalian females (89,90). Considerable excitement
was generated when experiments proved that 5-aza-CR
treatment reactivated the expression ofgeneslocated on
inactive mouse X chromosomes. Genes such as hypoxan-
thine guanine phosphoribosyl transferase (HPRT) (91)
andglucose-6-phosphate dehydrogenase(92)wereinduced
after drug treatment. The changes caused by 5-aza-CR
treatmentaremediatedatthelevelofDNA structure and
are heritable in the absence offurther analogtreatment.
This fact was demonstrated by the ability of DNA ex-
tracted from hybrid cell lines containing 5-aza-CR-
reactivatedX chromosomes to restore enzyme activity to
HPRT- recipient cells (93,94). Taken together, these
studies provide strong evidence that DNA methylation
mediates chromatin structure andX chromosome inacti-
vation as5-aza-CR induceshypomethylation, chromosome
decondensation (95) and gene activation.
Autosomal Gene Activation
Table 1 shows that 5-aza-CR stimulates the expression
of suppressed genes within a wide variety ofcell types.
One ofthemost dramatic 5-aza-CR-mediatedgene induc-
tions was a 10_- to 106-fold increase in thymidine kinase
expressionreportedby Harris(96). Genereactivationwas
observed in as many as 10 to 30% ofthe surviving cells,
whichis severalordersofmagnitude higherthanthatex-
pected for a mutagenic agent. 5-Aza-CR is in fact not
measurably mutagenicinmammalian cells(9?). Thisfind-
ing suggests that the absence of expression of some
housekeepinggenes can, inmany cases, be attributed to
altered, suppressive methylation patterns ratherthan to
classical mutations. 5-Aza-CR treatment can demethylate
those sites important for regulation ofgene activity so
that the genes can be reexpressed.
It should be emphasized that some genes are not
directly inducedby5-aza-CR treatment; exposure to the
analog is permissive but not sufficient for activation.
5-Aza-CR treatment ofmousethymomacellsdoesnotre-
sult in metallothionein gene expression unless a secon-
dary stimulus (e.g., heavy metal or steroid) is applied
(102), and no response is obtained with either individual
stimulus. A two-stage mechanism ofgene activation has
alsobeen observedforglobingeneexpressionin chickens,
withsodiumbutyrate asthe secondarystimulus(122),and
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Table 1. Induction of specific gene products by 5-azacytidine.
Gene activated System Reference
Thymidine kinase CHO hamster (96)
L5178Y mouse (98)
L-61-M mouse (99)
FEL mouse (100)
Herpes simplex (101)
Metallothionein W7 mouse (102)
CHO hamster (103)
Salmon embryo cells (104)
Hypoxanthine guanine Mouse-human hybrids (90)
phosphoribosyl transferase (105)
(91)
HeLa H23 human (106)
Globin Humans (107)
(108)
(109)
Baboon (110)
Mouse (111)
Prolactin GH3 rat pituitary (112)
Asparagine synthetase JR45 rat sarcoma (113)
CHO hamster (114)
Ornithine carbamoyl Rat hepatoma (115)
transferase
Ornithine decarboxylase CHO hamster (116)
Glutamine synthetase V79 hamster (117)
Phosphoenolpyruvate Rat (28)
carboxykinase
Interleukin 2 EL4 thymoma (118)
Tpyrosine aminotransferase Rat fetal liver (119)
Growth hormone Rat pituitary (120)
xrs gene: DNA repair gene CHO hamster (121)
in mouse-human hybrids responding to hexamethylene-
bis-acetamide after 5-aza-CR exposure (123). 5-Aza-CR
treatment failed to activate adeninephosphoribosyl trans-
ferase (124), or c-mos in 10TY2 cells (125) and did not en-
hance a-fetoprotein expression in differentiating F9 cells
(126). These experiments suggest that 5-aza-CR action
renders some genes poised for transcription but that
other trans-acting factors are necessary forexpression of
the gene. The chromatin structure associated with 5-aza-
CR-induced hypomethylation may represent the poten-
tially active conformation necessary but, in the absence
of trans-acting regulators, is not sufficient for gene ex-
pression. This theory would be consistent with a role of
methylation in chromatin compaction andthe consequen-
tial alteration of this structure by the methylation inhi-
bitors. In this way, methylation may be only one level of
the complex network system that regulates eukaryotic
gene expression.
Viral Gene Activation
The expression ofmany different endogenous and ex-
ogenous viruses has been inducedby5-aza-CR treatment
ofvarious cell types from several species(Thble 2). Early
studies revealed that 5-aza-CR induced the expression of
Rous sarcoma virus from hamster cells (127). Treatment
of chicken cells with 5-aza-CR caused hypomethylation
Table 2. Viral gene activation by 5-azacytidine.
Virus System Reference
Rous sarcoma virus Hamster cells (127)
Endogenous virus ev-1 Chicken cells (128)
Epstein Barr virus Human lymphoid cell (129)
lines
Hepatitis B virus core gene Human epithelial cell (130)
lines
Endogenous type C virus BALB mouse cells (131)
Endogenous viral proteins Mouse cells (132)
Moloney murine leukemia Mouse 3T3 cells (133)
virus
Moloney murine leukemia Mouse thymus, spleen, (134)
provirus and liver
Endogenous type C and type A Mouse 10T/2 cells (135)
retrovirus-related sequences
Murine leukemia provirus Mouse AKR cells (136)
Rous sarcoma virus Rat-1 cells (137)
Rat retrovirus Rat cells (138)
and transcriptional activation of the ev-1 endogenous
retroviral locus (128). Drug-induced activation ofviruses
in human (129,130), murine (131-136), and rat systems
(137,138)has alsobeenreported. In most cases, the inac-
tive proviral genomes were hypermethylated and ex-
hibited decreased 5-methylcytosine levels once activated
by 5-aza-CR treatment. These viral systems will be ex-
tremelyusefulforanalysis ofthe mechanisms ofviral sup-
pression in eukaryotic cells.
De Novo DNA Methylation
De novo DNA methylation is a characteristic ofearly
embryonic cells and may be responsible for the inactiva-
tion of genes during development (41). De novo meth-
yltransferase activity is thought to facilitate the repres-
sion of genes that are expressed during gametogenesis
but that are not required after fertilization. De novo
methylationcouldalsofunction to correct demethylation
errors introducedbythemaintenance methylase ingerm
cells.
Studies using viral infection of mouse cells demon-
strated that de novo methylation is active in pluripotent
cells of preimplantation mouse embryos, but not in
postimplantation ornewborn mice (41). De novo methyl-
ation of the exogenous sequences correlated with tran-
scriptional inactivity. Repressionofthistype ingenes not
needed early in development may therefore be essential
for maintenance of the pluripotential state of cells.
Groudine and Conklin proposed that de novo methyl-
ation of DNA during spermatogenesis would template
those genes not immediately needed in the embryo (37).
Conversely, genesprotectedfromde novomethylation at
specificpoint siteswould apparently be constitutively ex-
pressed inthe embryo. Proteinfactors orlocal chromatin
structure may inhibit theprocession ofthe methyltrans-
ferase enzyme along specific DNA sequences, thus pro-
tecting certain sites from becoming methylated. The
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hypomethylated state would ensurethatthese embryonic
genes remained in a transcriptionally competent config-
uration, thus permitting selective expression of certain
paternal genes early in development.
Temporal and regional genomic demethylation and pro-
gressive remethylation occurs during embryogenesis
(27,139). Embryonic and extraembryonic lineages are in-
dependently methylated, resulting in the observed tissue-
specific patterns of cytosine modification. Methylation
may therefore be associated with programming of cell
lineage determination in mammalian development.
DNA Methylation and Parental
Imprinting
Clear evidence exists that paternal and maternal ge-
nomes exert different functions duringembryogenesis in
the mouse (140). Development requires the concerted con-
tribution ofboth parental genomes, but distinct functions
depend on the parental origin ofthegenetic information.
For example, the paternal genome is largely responsible
for development of the mouse extraembryonic tissues,
whereas the maternal genome is more important for em-
bryonic development (141,142).
Parental imprinting is the molecular mechanism that
determines the differential expression of maternal and
paternal genomes duringembryogenesis and defines the
functional nonequivalence ofthe parental genomes. This
template information mustbe stable andheritable, must
persist during cell division, andmustbe capable ofaffect-
inggene expression. Forthese very criteria, DNAmeth-
ylation hasbecome an attractive model forthe epigenetic
programming ofparental genomes (143).
The role ofDNAmethylation ingenomicimprintinghas
been substantiated by very elegant experiments using
transgenicmice(12-14). Ineachcase, theinvestigatorsfol-
lowed the methylationpattern ofan autosomal transgene
that was randomly integrated into the mouse genome.
Since the transgene locus would only be transmitted to
50% oftheprogeny, appropriate crosseswoulddistinguish
between maternal or paternal inheritance of the trans-
gene, and correlations could be made between the meth-
ylation status and gametogenic history ofthe gene. The
studies showed that the methylation pattern of the ex-
ogenous DNA sequence could be switched between
maternal andpaternalpatterns depending onthegamete
oforigin in successive generations.
Swain et al. (14) ingeniously demonstrated that the
methylation pattern, as well as the potential for expres-
sion ofatransgene, weregovernedbytheparentalorigin
ofthe RSV-myc fusion transgene The methylation pat-
tern ofthe transgene was differentiallyimprintedduring
gametogenesis intheparent orveryearlyinembryogen-
esis ofthe offspring. Ifthe transgene was inheritedfrom
a paternal source, expression was detected in offspring
heart tissue only, whereas inheritancefromthematernal
genomeprecluded transgene expression. The expressed
transgene was relatively undermethylated when in-
heritedfromthe maleparent, whereas thetransgenic al-
lele ofmaternal origin was more methylated and not ex-
pressed. Autosomal gene expression was thusinfluenced
by the sex ofthe parent that transmitted the gene. Fur-
thermore, hypomethylation was necessary but not suffi-
cientforexpression ofthetransgene in tissuesotherthan
the heart.
These studies provide strong evidence linking methyl-
ation with parental imprinting of certain genes. On a
global level, sperm DNAis more methylated than oocyte
DNA, but imprinting could be achieved by differential
modulation ofmethylation at specific domains in the ga-
mete DNA. Future studies will elucidate whether DNA
methylation is aprimary signal inimprinting orwhether
it is a consequence ofother chromosomal modifications.
This work was supported by Public Health Service grant CA 39913
from the National Cancer Institute and by the California Foundation
for Biochemical Research.
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